Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2003
11/05/2003CN1452963A Metronidazole prepn
11/05/2003CN1452962A Medicine composition of maleic acid and Tegaserod and its prepn
11/05/2003CN1126930C Desiccant, dehydration therewith and dehydrated product obtainable thereby
11/05/2003CN1126574C Intravaginal releasing system
11/05/2003CN1126568C Adjuvant used in vaccine
11/05/2003CN1126564C Application of phospholipid complexes of extracts of civitis vinifera as anti-atherosclerotic agent
11/05/2003CN1126560C Chinese patent medicine for treating gastrointestinal diseases
11/05/2003CN1126556C Lumbago plaster
11/05/2003CN1126550C Chinese herb medicine solution for treating anal firstula
11/05/2003CN1126547C Lentinan holosida freeze-dried powder injecta and its preparation
11/05/2003CN1126544C Shuangmidamo suppository and its preparing process
11/05/2003CN1126543C Pharmaceutical composition for oral administration of N-piperidino-3-phrazolecarboxamide derivative, its salts and their solvates
11/05/2003CN1126540C Plaster containing felbinac
11/05/2003CN1126537C Locally administrable, biodegradable and sustained-release pharmaceutical composition for treating periodontitis and preparation thereof
11/05/2003CN1126536C Pharmaceutical composition for controlling release of active substances
11/05/2003CN1126535C Aqueous suspension for nasal administration of loteprednol
11/05/2003CN1126533C Improvement of organic composition or improvement related to organic composition
11/04/2003US6642411 Compounds and compositions for delivering active agents
11/04/2003US6642363 Bonded to a peptide which promotes cell adhesion and growth; use in drug delivery, cell transplantation and tissue engineering
11/04/2003US6642276 Controlled release macrolide pharmaceutical formulations
11/04/2003US6642275 Formulation for respiratory tract administration
11/04/2003US6642271 Potentiating compounds
11/04/2003US6642238 Microbiocides against grampositive and gramnegative bacteria
11/04/2003US6642212 Health supplement comprising naturally occurring phytoestrogen selected from any two or more of genistein, daidzein and/or their glycosides
11/04/2003US6642205 Methods and compositions for reducing side effects in chemotherapeutic treatments
11/04/2003US6642193 Contacting hair and skin with effective conditioning amount of compound made by reacting epoxysuccinic acid and salt of alkyl alkoxylated surfactant in aqueous solution
11/04/2003US6642192 Amphoteric surfactants based upon epoxy succinic acid in personal care applications
11/04/2003US6642010 Identifying, monitoring, and treating women for breast precancer or cancer
11/04/2003US6641844 Rotating in situ to fineness; micronized drugs for pulmonary administration; inhalants
11/04/2003US6641843 Pharmaceutical compositions
11/04/2003US6641841 N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and low sustituted hydroxypropylcellulose; controlling the blood sugar levels of diabetics.
11/04/2003US6641840 Sustained release formulations for growth hormone secretagogues
11/04/2003US6641839 Isosorbide mononitrate coated sugar or nonpareil core; time-release agents; diffusion control membrane; prevents nitrate tolerance
11/04/2003US6641838 Effervescent drug delivery system for oral administration
11/04/2003US6641837 Flavored vegetable starch capsule
11/04/2003US6641834 Quinoxaline component is selected from qinoxaline, a (2-imiozoline -2-ylamino) quinoxaline, a 5-bromo-6-(2-imidozolin-2- ylamino) quinoxaline, a tartrate of 5-bromo-6-(2-imidozolin-2-ylamino) quinoxaline or derivatives
11/04/2003US6641833 Extended release of paclitaxel by intraperitoneal administration
11/04/2003US6641832 Increasing blood flow to tissue with angiogenic material containing polymer and vascularizing compound
11/04/2003US6641831 Nondegradable; monolithic distribution of substances having different hydrophilicity dispersed in polymeric matrix
11/04/2003US6641822 Composition containing humidity regulators for preparing tissue products
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
11/04/2003US6641800 Administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer soluble in the liquefied hydrofluoroalkane which is selected from polymers
11/04/2003US6641799 Nasal spray for decongesting nasal passages
11/04/2003US6641063 Milling process for the production of finely milled medicinal substances
11/04/2003CA2175470C Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
10/2003
10/30/2003WO2003089568A2 Method of inhibiting restenosis
10/30/2003WO2003089506A1 Hydrogels having enhanced elasticity and mechanical strength properties
10/30/2003WO2003089458A2 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003WO2003089423A2 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents
10/30/2003WO2003089046A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003WO2003089032A2 Implantable infusion device with optimized peristaltic pump motor drive
10/30/2003WO2003089025A1 Patch stabilization of rods for treatment of cardiac muscle
10/30/2003WO2003089009A1 Microparticles comprising carbohydrate beads covalently linked with allergen
10/30/2003WO2003089008A1 Novel biomaterials, their preparation and use
10/30/2003WO2003089002A1 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
10/30/2003WO2003089001A1 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
10/30/2003WO2003088987A1 Composition obtained from barley shochu stillage and having effects of inhibiting the onset of alcoholic liver injury and healing it as well as favorable taste, and process for producing the same
10/30/2003WO2003088985A2 Use of compositions containing petasites for treating diseases
10/30/2003WO2003088974A1 Pharmaceutical composition
10/30/2003WO2003088966A1 The use of hydroxypyridone-derivatives in wound healing
10/30/2003WO2003088952A1 Sustained release of guaifenesin combination drugs
10/30/2003WO2003088951A1 Formulation of fine particles using liquefied or dense gases
10/30/2003WO2003088950A1 System for enhanced targeted delivery
10/30/2003WO2003088949A2 Matrix comprising a bioactive component containing phospholipid
10/30/2003WO2003088948A2 Microemulsions for selective molecular separation
10/30/2003WO2003088946A1 Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088944A1 Dry powder inhalant composition
10/30/2003WO2003088943A1 Dry powder compositions
10/30/2003WO2003088933A1 Moisture triggered release systems comprising aroma ingredients providing fragrance burst in response to moisture
10/30/2003WO2003088923A2 Methods of treating ileus
10/30/2003WO2003088894A2 A multi component controlled release system for anhydrous cosmetic compositions
10/30/2003WO2003088883A1 Combination of ablation and controlled drug delivery for the tre atment of cancer
10/30/2003WO2003088880A2 Condom
10/30/2003WO2003088765A2 Functional foods containing a phospholipid-containing stable matrix
10/30/2003WO2003088761A2 Physiologically compatible, phospholipid-containing, stable and hard matrix
10/30/2003WO2003053414A3 Triggered release from proteinoid microspheres
10/30/2003WO2003053365A3 Syn3 compositions and methods
10/30/2003WO2003051378A3 Pharmaceutical composition for topical treatment of skin disorders and skin wounds
10/30/2003WO2003051294A3 Mitocidal compositions and methods
10/30/2003WO2003051293A3 Antidiabetic formulation and method
10/30/2003WO2003049783A3 Device and methods for harvesting tissue samples of known geometry
10/30/2003WO2003049701A3 Methods and products useful in the formation and isolation of microparticles
10/30/2003WO2003049680A3 Compositions containing both sedative and non-sedative antihistamines
10/30/2003WO2003047633A3 Treatment of angiogenesis disorders using targeted nanoparticles
10/30/2003WO2003047529A3 Extended release pharmaceutical tablet of metformin
10/30/2003WO2003024455A3 Stent coated with a sustained-release drug delivery and method for use thereof
10/30/2003WO2003022243A3 Sustained release of microcrystalline peptide suspensions
10/30/2003WO2003020320A3 Nanoparticles comprising biologically active tnf which is immobilised on the same
10/30/2003WO2003014305A3 Eukaryotic cells and method for preserving cells
10/30/2003WO2003013610A3 Surfactant compounds and uses thereof
10/30/2003WO2003013441A3 Levothyroxine compositions and methods
10/30/2003WO2002100548A3 Centrifuged rotating drum for treating cohesive powders
10/30/2003WO2002100389A3 Compressible guaifenesin compositions and method for producing them
10/30/2003WO2002098391A3 Process for preparing granular compositions
10/30/2003WO2002089699A9 Medical device and methods of use for glaucoma treatment
10/30/2003WO2002087563A3 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
10/30/2003WO2002080978A3 Pharmaceutical compositions comprising ascomycin
10/30/2003WO2002064162A3 Vaccine for transcutaneous immunization
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
1 ... 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 ... 2991